Executive and operating senior leadership experience in start-ups and publicly traded life sciences companies with track record in company formation, raising capital, strategy and business development, building and scaling R&D driven commercial businesses. Currently leading a VC backed pre-clinical stage company that is developing therapeutics based on its proprietary CRISPR based genome editing platform and a proprietary LNP based platform for delivery of genetic materials to the Central Nervous System. Prior track record in leading a commercial organization and clinical stage R&D pipeline. Oversaw approval of multiple NDAs and commercial product launches.Multi-disciplinary hands-on experience in managing R&D and product launch and commercialization (US P&L). Executed multiple early and commercial stage licensing transactions (>$500 MM) and R&D collaborations.Prior roles in international/global marketing (Abbvie and BMS) including new product launch (including launch of HUMIRA), portfolio and strategic planning. Also worked as a management consultant at Booz & co (Booz Allen Hamilton) addressing C-level business issues across multiple industry sectors.
Listed skills include Pharmaceutical Industry, Product Launch, Strategy, Biotechnology, and 19 others.
